Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2023-08-02 Earnings Release
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a press release announcing the upcoming release date of Cresco Labs' second quarter 2023 financial results and the scheduling of a conference call to discuss these results. It does not contain any actual financial data or detailed financial statements. The document length is only 2500 characters, which is short and typical for an earnings release announcement rather than the full earnings release itself. Therefore, this document is best classified as an Earnings Release (ER) announcement, which is the initial announcement of quarterly financial results and related conference call details. Q2 2023
2023-08-02 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing the mutual termination of a previously planned merger agreement between Cresco Labs and Columbia Care. It details the termination of the definitive arrangement agreement and related asset divestiture agreements. The content focuses on the cancellation of a merger transaction rather than the merger itself or any financial results. There are no financial statements, detailed financial analysis, or regulatory filings such as 10-K or 10-Q reports. The document is not a merger proxy statement or tender offer filing but an announcement about the termination of a merger agreement. Therefore, the document fits best into the category of M&A Activity (TAR), which covers announcements related to merger proposals or takeover bids, including their termination.
2023-07-31 English
News release - English.pdf
Regulatory Filings
2023-07-20 English
News release - English.pdf
Regulatory Filings
2023-07-04 English
News release - English.pdf
Regulatory Filings
2023-06-30 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the opening of two new dispensaries by Cresco Labs in Pennsylvania. It contains no financial data, no regulatory filing references, no voting results, no management or board changes, no earnings or interim report data, and no mention of any report publication. The content is purely an operational business update about expansion and new store openings. This type of announcement does not fit into financial report categories or regulatory filings but is a general corporate announcement. Given the definitions, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous corporate announcements that do not fit other specific categories.
2023-06-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.